Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
SMS PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 14.4512.358.4110.144.33

What is the latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SMS PHARMACEUTICALS is 14.45 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202414.45
Mar202312.35
Mar20228.41
Mar202110.14
Mar20204.33

How is EV/Core EBITDA of SMS PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 14.45
17.00
Mar2023 12.35
46.85
Mar2022 8.41
-17.06
Mar2021 10.14
134.18
Mar2020 4.33 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹2,104.9 Cr -2.2% -6.8% -6.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,919.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -4.3% -8% -4.4% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-2.2%

-6.8%

-6.8%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses